A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer	Bone Diseases, Developmental, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniofacial Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Limb Deformities, Congenital, Male Urogenital Diseases, Musculoskeletal Abnormalities, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, bone disorder, craniosynostosis, dysostosis, musculoskeletal system disorder, neoplasm, syndactyly, synostosis, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder	Active, not recruiting	Phase 1	2026-08-28		NCT05567185

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Janssen Pharmaceutical K.K.	3

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Osaka International Cancer Institute	Osaka	Japan	9
St Marianna University Hospital	Kanagawa	Japan	7
Toyama University Hospital	Toyama	Japan	14
University of Tsukuba Hospital	Tsukuba	Japan	6